INTRAUTERINE COPPER CONTRACEPTIVE

Intrauterine Copper Contraceptive Adverse Events Reported to the FDA Over Time

How are Intrauterine Copper Contraceptive adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Intrauterine Copper Contraceptive, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Intrauterine Copper Contraceptive is flagged as the suspect drug causing the adverse event.

Most Common Intrauterine Copper Contraceptive Adverse Events Reported to the FDA

What are the most common Intrauterine Copper Contraceptive adverse events reported to the FDA?

Iucd Complication	59 (10.85%)
Iud Migration	35 (6.43%)
Abdominal Pain	32 (5.88%)
Unintended Pregnancy	28 (5.15%)
Vaginal Haemorrhage	28 (5.15%)
Ectopic Pregnancy	17 (3.13%)
Metrorrhagia	14 (2.57%)
Intra-uterine Contraceptive Device ...	13 (2.39%)
Abortion Spontaneous	12 (2.21%)
Medical Device Complication	12 (2.21%)
Pregnancy With Contraceptive Device	12 (2.21%)
	Show More
Menorrhagia	8 (1.47%)
Nausea	7 (1.29%)
Pain	7 (1.29%)
Pelvic Inflammatory Disease	7 (1.29%)
Pelvic Pain	7 (1.29%)
Chorioamnionitis	6 (1.1%)
Dehydration	5 (.92%)
Ovarian Cyst	5 (.92%)
Dizziness	4 (.74%)
Menstruation Irregular	4 (.74%)
Pyrexia	4 (.74%)
Syncope	4 (.74%)
Vaginal Infection	4 (.74%)
Weight Increased	4 (.74%)
Abdominal Discomfort	3 (.55%)
Abdominal Distension	3 (.55%)
Abdominal Pain Lower	3 (.55%)
Abscess	3 (.55%)
Anaemia	3 (.55%)
Asthenia	3 (.55%)
Caesarean Section	3 (.55%)
Constipation	3 (.55%)
Device Dislocation	3 (.55%)
Drug Exposure During Pregnancy	3 (.55%)
Dysmenorrhoea	3 (.55%)
Malaise	3 (.55%)
Meningitis	3 (.55%)
Menstruation Delayed	3 (.55%)
Pruritus	3 (.55%)
Pyelonephritis	3 (.55%)
Sinusitis	3 (.55%)
Stillbirth	3 (.55%)
Tubo-ovarian Abscess	3 (.55%)
Uterine Contractions During Pregnan...	3 (.55%)
Uterine Haemorrhage	3 (.55%)
Abdominal Adhesions	2 (.37%)
Abortion Infected	2 (.37%)
Back Pain	2 (.37%)
Beta Haemolytic Streptococcal Infec...	2 (.37%)
Breech Presentation	2 (.37%)
Chills	2 (.37%)
Complication Of Device Removal	2 (.37%)
Disease Recurrence	2 (.37%)
Disseminated Intravascular Coagulat...	2 (.37%)
Endometritis	2 (.37%)
Erythema	2 (.37%)
Fallopian Tube Disorder	2 (.37%)
Headache	2 (.37%)
Hypomenorrhoea	2 (.37%)
Infection	2 (.37%)
Intra-uterine Death	2 (.37%)
Medical Device Pain	2 (.37%)
Photosensitivity Allergic Reaction	2 (.37%)
Pregnancy	2 (.37%)
Sciatica	2 (.37%)
Urinary Tract Infection	2 (.37%)
Uterine Leiomyoma	2 (.37%)
Uterine Polyp	2 (.37%)
Abdominal Abscess	1 (.18%)
Abortion	1 (.18%)
Abortion Induced	1 (.18%)
Adhesion	1 (.18%)
Alopecia	1 (.18%)
Amenorrhoea	1 (.18%)
Amniotic Fluid Volume Increased	1 (.18%)
Anorectal Disorder	1 (.18%)
Ascites	1 (.18%)
Back Injury	1 (.18%)
Breast Cancer Female	1 (.18%)
Bronchitis	1 (.18%)
Calculus Bladder	1 (.18%)
Candidiasis	1 (.18%)
Cervical Dysplasia	1 (.18%)
Chest Pain	1 (.18%)
Cholelithiasis	1 (.18%)
Cold Sweat	1 (.18%)
Convulsion	1 (.18%)
Csf Glucose Decreased	1 (.18%)
Csf Pressure Increased	1 (.18%)
Csf Protein Increased	1 (.18%)
Csf White Blood Cell Count Increase...	1 (.18%)
Depressed Level Of Consciousness	1 (.18%)
Device Breakage	1 (.18%)
Device Failure	1 (.18%)
Device Related Infection	1 (.18%)
Discomfort	1 (.18%)
Disorientation	1 (.18%)
Drug Ineffective	1 (.18%)
Dysarthria	1 (.18%)
Dysgeusia	1 (.18%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Intrauterine Copper Contraceptive, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Intrauterine Copper Contraceptive is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Intrauterine Copper Contraceptive

What are the most common Intrauterine Copper Contraceptive adverse events reported to the FDA?

Procedural And Device Related Injur...	129 (23.71%)
Gastrointestinal Signs	50 (9.19%)
Pregnancy, Labour, Delivery And Pos...	45 (8.27%)
Infections - Pathogen Unspecified	40 (7.35%)
Menstrual Cycle And Uterine Bleedin...	36 (6.62%)
Vulvovaginal Disorders	29 (5.33%)
Abortions And Stillbirth	18 (3.31%)
Maternal Complications Of Pregnancy	18 (3.31%)
Neurological	12 (2.21%)
Uterine, Pelvic And Broad Ligament	10 (1.84%)
Ovarian And Fallopian Tube	9 (1.65%)
	Show More
Epidermal And Dermal Conditions	7 (1.29%)
Hematology Investigations	7 (1.29%)
Placental, Amniotic And Cavity Diso...	7 (1.29%)
Reproductive Tract	7 (1.29%)
Electrolyte And Fluid Balance Condi...	5 (.92%)
Musculoskeletal And Connective Tiss...	5 (.92%)
Body Temperature Conditions	4 (.74%)
Neurological, Special Senses And Ps...	4 (.74%)
Obstetric And Gynecological Therape...	4 (.74%)
Peritoneal And Retroperitoneal Cond...	4 (.74%)
Physical Examination Topics	4 (.74%)
Skin Appendage Conditions	4 (.74%)
Anemias Nonhemolytic And Marrow Dep...	3 (.55%)
Bacterial Infectious	3 (.55%)
Chemical Injury And Poisoning	3 (.55%)
Gastrointestinal Motility And Defec...	3 (.55%)
Injuries	3 (.55%)
Maternal Complications Of Labour An...	3 (.55%)
Renal And Urinary Tract Investigati...	3 (.55%)
Cervix Disorders	2 (.37%)
Coagulopathies And Bleeding Diathes...	2 (.37%)
Embolism And Thrombosis	2 (.37%)
Fetal Complications	2 (.37%)
Headaches	2 (.37%)
Reproductive Neoplasms Female Benig...	2 (.37%)
Spinal Cord And Nerve Root	2 (.37%)
Allergic Conditions	1 (.18%)
Anal And Rectal Conditions	1 (.18%)
Angiedema And Urticaria	1 (.18%)
Arteriosclerosis, Stenosis, Vascula...	1 (.18%)
Breast Neoplasms Malignant And Unsp...	1 (.18%)
Cardiac Disorder Signs	1 (.18%)
Decreased And Nonspecific Blood Pre...	1 (.18%)
Deliria	1 (.18%)
Fetal And Neonatal	1 (.18%)
Fungal Infectious	1 (.18%)
Gallbladder	1 (.18%)
Gastrointestinal Hemorrhages	1 (.18%)
Gastrointestinal Therapeutic Proced...	1 (.18%)
Gastrointestinal Ulceration And Per...	1 (.18%)
Muscle	1 (.18%)
Musculoskeletal And Connective Tiss...	1 (.18%)
Protozoal Infectious	1 (.18%)
Seizures	1 (.18%)
Sexual Dysfunctions, Disturbances A...	1 (.18%)
Sexual Function And Fertility	1 (.18%)
Therapeutic And Nontherapeutic Effe...	1 (.18%)
Therapeutic Procedures And Supporti...	1 (.18%)
Tissue	1 (.18%)
Urinary Tract Signs	1 (.18%)
Urolithiases	1 (.18%)
Vascular	1 (.18%)
Vascular Hemorrhagic	1 (.18%)
Vascular Hypertensive	1 (.18%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Intrauterine Copper Contraceptive, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Intrauterine Copper Contraceptive is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.